Meningococcal carriage and infection: technical background

Main messages

Meningococcal carriage is common in young adults (5 to 10% may carry the bacteria). 

Disease is rare, but severe and fast-moving. 

Young adults matter because they drive transmission, not because they are the group with the highest absolute disease burden. 

The transition from harmless colonisation to invasive disease is unusual, but when it happens it is often catastrophic. 

Vaccination, especially adolescent MenACWY programmes, matters partly because it can suppress carriage and generate herd protection. 

Overview of meningococcal carriage and infection in young adults

Meningococcal carriage means Neisseria meningitidis is living in the back of the nose or throat without causing illness. In young adults – especially adolescents, university students, and others in dense social settings – carriage is common and is usually harmless. The problem is that carriers are the reservoir for transmission and can pass the bacteria to others. On rare occasions, the organism breaches the mucosal barrier in the nose and throat, enters the bloodstream, and causes invasive meningococcal disease (IMD) such as septicaemia or meningitis. 

Importance of young adults in meningococcal transmission

Young adults are central to meningococcal epidemiology for 2 reasons: they often have the highest carriage rates, and they have behavioural and environmental exposures that promote spread. These include close social mixing, living in a household type set-up in freshers’ halls or dormitories, intimate kissing, and crowded indoor settings. That is why this age group is both an important transmission hub and a target for vaccination strategies designed not just to protect individuals, but to reduce carriage and create herd protection. This is the purpose of the MenACWY vaccine in young adults. However, the MenB vaccine does not reduce carriage or create herd (indirect) protection. It does provide direct protection to the individual against invasive disease against 75% to 85% of strains currently circulating in the UK.

Biological features of meningococcal carriage

The organism colonises the nose and throat. Most of the time, host immunity, local mucosal defences, and bacterial factors remain in balance, so the person stays well. Many strains carried are less invasive and, even strains capable of causing disease usually remain confined to the mucosal surface. Carriage can be transient, intermittent, or more prolonged, and people may acquire and clear meningococci without ever knowing. 

Mechanisms leading from carriage to invasive disease

The important step is not carriage itself, but invasion. A carried meningococcus has to breach the mucosal barrier, evade the immune system, and survive in blood. Disease is therefore the result of a combination of: 

• a susceptible host 
• a sufficiently virulent strain 
• the right biological moment for invasion 

That is why carriage is common but invasive disease is rare. Most carriers never become ill. Invasive meningococcal disease (IMD) is an accident of host-pathogen interaction, not the usual outcome of colonisation. 

Periods of increased risk for invasive disease

The risk of invasive disease appears to be highest soon after a new strain is acquired and before protective immunity has had time to develop. In practical terms, rapid circulation of strains in settings with intense mixing creates more opportunity for recent acquisition events, which is one reason universities and similar settings can see clusters or outbreaks even though the absolute incidence remains low. 

Risk factors among young adults

Not all young adults are at equal risk of exposure. Risk is higher in those with: 

• recent entry into shared accommodation such as halls or dormitories or military barracks 
• intense social mixing 
• active smoking or exposure to cigarette smoke (this is thought to increase risk in 2 ways: by prolonged close proximity while engaging in the activity, and through the effects of smoke on the respiratory tract) – there is less evidence but similar scientific rationale for vapes
• close intimate contact 
• immune system deficiencies (such as splenic dysfunction or compliment disorders) do not affect risk of exposure, but do increase risk of disease 

Freshers (first year entrants into university) are a classic high-risk group because they are suddenly exposed to new networks and new strains. 

Significant meningococcal strains in the UK

Many serogroups of the meningococcus exist, but in the UK the most important causes of invasive disease in recent years have included B, C, W and Y. Carriage does not map perfectly onto disease: a strain may circulate widely in throats yet cause few invasive cases, while a hyperinvasive lineage can cause disproportionate severe disease. This is why public health concern focuses not only on ‘how much carriage’ there is, but which strains and clonal complexes are circulating. 

Transmission dynamics in universities and similar settings

Universities are not uniquely dangerous; they are just an efficient transmission environment: 

• large numbers of young adults 
• new contact networks 
• shared accommodation 
• close contact in bars, parties, nightclubs, and prolonged indoor exposure 
• delayed recognition because early symptoms can look like flu or a viral illness or a hangover 

UK and international data show increased carriage and outbreak potential in student settings, including Group W and Group B episodes. 

Symptoms indicative of progression to invasive disease

Once invasion occurs, illness can progress rapidly. Early features may be nonspecific: fever, headache, myalgia, vomiting, lethargy. They can then evolve into meningitis, septicaemia, rash, shock, reduced consciousness, or death. Young adults are not protected by being otherwise fit and healthy. The disease is uncommon, but when it occurs it constitutes a true medical emergency 

Role of vaccination in individual and population protection

Vaccination works in 2 distinct ways: 

MenACWY conjugate vaccines: 

• protect vaccinated individuals against covered serogroups 
• can also reduce carriage and transmission, which is why adolescent programmes have herd protection effects across the population 

MenB vaccines: 

• are designed mainly for direct protection against disease 
• there is no protection against carriage of MenB strains, so they cannot provide herd immunity in the same way 

This distinction matters. If the goal is to cut transmission in adolescents and young adults, conjugate vaccine programmes but not MenB vaccines have a stronger track record for that purpose. 

The Men B vaccine is given as 2 doses at least 4 weeks apart. Vaccination does not protect straight away – it takes at least 2 weeks from the second dose of vaccine for the body to produce antibodies to give a good level of protection.

Public health actions relating to carriers and close contacts

Public health action in an outbreak scenario is not aimed at random carriers in the population. It focuses on: 

• rapid treatment of cases 
• chemoprophylaxis (antibiotics) for close contacts and, sometimes, social networks 
• vaccination of those at increased ongoing risk of exposure, depending on serogroup and setting 
• communication to high-risk groups such as university communities 

The logic is to eliminate carriage in those most likely to have acquired the same strain as the case using antibiotics, and prevent onward transmission or secondary cases. 

However, some individuals may not consider themselves at risk and won’t come forward for antibiotics or vaccines and, therefore, even after large campaigns in outbreaks, subsequent sporadic cases with the same strain may be detected for weeks to months and may even become the wider dominant strain across the population.

Sources of evidence and further reading

Green Book, chapter 22: meningococcal disease and vaccination

UKHSA Meningococcal disease: guidance on public health management disease

Burman and others, review on meningococcal disease in adolescents and young adults